Stay updated on Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page, indicating a new version of the page. This is a minor, administrative update rather than a substantive change to the study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe publications section citation for the related Oncologist article was updated to reflect the finalized issue date/details instead of an online-ahead-of-print entry. The page revision/version label was also updated (v3.5.2 to v3.5.3).SummaryDifference0.1%

- Check31 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded publication reference: Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Semin Cancer Biol. 2025;109:101-124 (Epub Jan 23, 2025).SummaryDifference0.1%

- Check60 days agoChange DetectedAdded a Publications entry for the 2026 Oncologist article with PubMed auto-fill notes and removed the Revision: v3.4.3 entry.SummaryDifference0.3%

- Check67 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.